
ALT Dr. Donald MacIntyre, Network Director for NHS Research Scotland Mental Health Network, with a landscape in the background. A text overlay reads: "After a global mental health crisis exacerbated by COVID-19, the need to address TRD and other forms of depression is increasingly a priority, particularly when existing therapies fail to have a consistently positive impact on those who are worst affected." NHS Research Scotland logos included.

ALT This image features an informational graphic from NHS Research Scotland. On the left side of the image, there is a light blue banner with text that reads "In the news." Below this, larger text states, "Patients with treatment-resistant depression to take part in psychedelic treatment study this year," with a publication date of "24 May 2024." There is a link for more information: "nrs.org.uk/news." The right side of the graphic displays two individuals seated across from each other in a room, engaged in conversation. The surroundings suggest a comfortable, indoor setting. Additionally, there are decorative graphics involving circles and dots in shades of blue, encapsulating the scene and text.

ALT Catherine Deith, Network Manager for the NHS Research Scotland Mental Health Network, pictured alongside the quote: "We believe that this is a valuable opportunity for researchers to open up vital new avenues of education that can accelerate their development, and it’s important that our workforce is aware of it."

ALT Dr Donald Macintyre, Research Lead for the NHS Research Scotland Mental Health Network, pictured alongside the quote: "The fund underlines our need for collaboration at an important time, and the desire to bring key national and international learnings back, not only to the Network, but Scotland as a whole in order to increase the quality of mental health research."


















